Noronex clears new share issue for on-sale under Corporations Act exemption

Noronex Ltd. ( (AU:NRX) ) has issued an update.

Noronex Limited has issued 9,069,921 fully paid ordinary shares and notified the market that these securities qualify for on-sale without a disclosure document under section 708A(5) of the Corporations Act 2001. The company confirmed it is up to date with its financial reporting and continuous disclosure obligations and stated there is no undisclosed information that investors would reasonably require to assess its financial position or the rights attached to the new shares.

The notice means the newly issued shares can be freely traded by investors relying on the statutory exemption, supporting liquidity in Noronex’s stock while affirming regulatory compliance. The board’s authorisation of the announcement signals that governance processes have been followed in connection with the capital issuance and subsequent secondary trading arrangements for the new equity.

The most recent analyst rating on (AU:NRX) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Noronex Ltd. stock, see the AU:NRX Stock Forecast page.

More about Noronex Ltd.

Noronex Limited is an Australia-based company listed on the ASX under the ticker NRX. The company operates in the resources sector, with its corporate headquarters in Subiaco, Western Australia, and is overseen by a board including a chairman, managing director and CEO, non-executive directors and a chief geologist.

Average Trading Volume: 1,091,651

Technical Sentiment Signal: Sell

Current Market Cap: A$6.29M

For detailed information about NRX stock, go to TipRanks’ Stock Analysis page.